Regions Financial Corp Horizon Therapeutics Public LTD CO Transaction History

Regions Financial Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$62.39 - $113.8 $2,058 - $3,755	-33 Reduced 0.62%	5,312 $604,000
Q3 2022 Nov 03, 2022	SELL	$58.92 - $84.67 $99,633 - $143,176	-1,691 Reduced 24.03%	5,345 $331,000
Q2 2022 Jul 25, 2022	BUY	$79.4 - $116.36 $11,830 - $17,337	149 Added 2.16%	7,036 $561,000
Q1 2022 Apr 25, 2022	BUY	$86.42 - $109.81 $20,827 - $26,464	241 Added 3.63%	6,887 $725,000
Q4 2021 Jan 31, 2022	BUY	$98.56 - $119.91 $689 - $839	7 Added 0.11%	6,646 $716,000
Q3 2021 Nov 04, 2021	BUY	$91.91 - $110.37 $42,462 - $50,990	462 Added 7.48%	6,639 $727,000
Q2 2021 Jul 27, 2021	BUY	$86.24 - $95.92 $121,770 - $135,439	1,412 Added 29.63%	6,177 $578,000
Q1 2021 Jun 02, 2021	BUY	$71.83 - $95.48 $135,327 - $179,884	1,884 Added 65.39%	4,765 $439,000
Q4 2020 Feb 05, 2021	BUY	$67.0 - $84.39 $193,027 - $243,127	2,881 New	2,881 $211,000
Q2 2020 Jul 27, 2020	SELL	$30.2 - $56.98 $351,044 - $662,335	-11,624 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$24.87 - $38.56 $101,121 - $156,784	-4,066 Reduced 25.91%	11,624 $344,000
Q4 2019 Feb 03, 2020	SELL	$25.43 - $36.67 $6,713 - $9,680	-264 Reduced 1.65%	15,690 $568,000
Q3 2019 Oct 24, 2019	BUY	$23.0 - $27.97 $366,942 - $446,233	15,954 New	15,954 $434,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.